2.100
+1,94%
2026-10-19
Fundamental Analysis
69 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +310.5% | +128.5% | 2 / 3 | +0.9% | +5.53 pp | +3.79 pp | +7.8% | 0.96 | 3.59 | 226 | +0,9% | 5,8 | +310,5% | 3.59 | 14.09 | −74,5% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 2.100 (close price on 2026-10-19)EPS (TTM): 585,4
Financial charts
1.Revenue & growth
VND bn226Q3/26
1.Revenue & growth
VND bn226Q3/26
2.Profit & growth
VND bn5,78Q3/26
3.Profit mix (Penman)
VND bn25,8Q3/26
4.Margins & cost structure
%12.0%Q3/26
5.Returns & cash cycle
% · days0.8%Q3/26
6.Earnings quality & cash
VND bn43,1Q3/26
7.Asset structure
VND bn812Q3/26
8.Funding & debt health
VND bn · times812Q3/26
9.Revenue backlog
VND bn14,8Q3/26
10.Valuation
times · %3,7×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %127Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26